In addition, it led to new biological findings concerning molecular paths in breast cancer cells linking the tyrosine kinase Syk and two targets involved in cell adhesion and motility: (i) the signaling axis Syk-Src-cortactin and (ii) the direct action of Syk on ezrin. This evidence concerns the gene SRC and breast carcinoma.